Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Teradata Corp
TDC
5
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.15%95.63M | 1.94%24.38M | 2.84%24.18M | 2.25%23.78M | 1.57%23.3M | 32.74%93.62M | 5.29%23.91M | 8.36%23.51M | 58.36%23.26M | 100.62%22.94M |
Operating revenue | 1.83%94.77M | 0.66%23.52M | 2.84%24.18M | 2.25%23.78M | 1.57%23.3M | 31.98%93.07M | 2.88%23.37M | 8.39%23.51M | 58.38%23.26M | 100.69%22.94M |
Cost of revenue | 4.15%43.56M | 6.70%10.94M | 5.71%11.19M | 2.83%10.85M | 1.39%10.58M | 36.86%41.82M | -0.06%10.26M | 15.10%10.58M | 66.16%10.55M | 119.52%10.43M |
Gross profit | 0.54%52.08M | -1.63%13.43M | 0.49%12.99M | 1.77%12.93M | 1.71%12.72M | 29.59%51.8M | 9.70%13.66M | 3.40%12.93M | 52.42%12.71M | 87.17%12.51M |
Operating expense | -4.84%41.79M | 7.20%10.62M | -2.38%10.31M | -9.76%10.28M | -12.24%10.59M | 11.28%43.92M | -16.41%9.9M | -10.79%10.56M | 33.34%11.39M | 66.64%12.06M |
Selling and administrative expenses | 1.05%15.6M | 8.71%3.82M | -5.13%3.81M | -0.91%3.81M | 2.39%4.15M | 5.32%15.43M | -7.92%3.51M | 9.37%4.02M | 8.92%3.85M | 11.62%4.06M |
-General and administrative expense | 1.05%15.6M | 8.71%3.82M | -5.13%3.81M | -0.91%3.81M | 2.39%4.15M | 5.32%15.43M | -7.92%3.51M | 9.37%4.02M | 8.92%3.85M | 11.62%4.06M |
Depreciation amortization depletion | -8.98%25.93M | 2.14%6.53M | -0.69%6.5M | -14.28%6.47M | -19.64%6.44M | 14.80%28.48M | -20.45%6.39M | -19.85%6.54M | 50.56%7.54M | 122.07%8.01M |
-Depreciation and amortization | -8.98%25.93M | 2.14%6.53M | -0.69%6.5M | -14.28%6.47M | -19.64%6.44M | 14.80%28.48M | -20.45%6.39M | -19.85%6.54M | 50.56%7.54M | 122.07%8.01M |
Provision for doubtful accounts | --270K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Operating profit | 30.52%10.28M | -24.93%2.82M | 13.27%2.68M | 101.60%2.65M | 382.35%2.13M | 1,466.40%7.88M | 522.72%3.76M | 256.33%2.37M | 738.83%1.32M | 179.21%442K |
Net non-operating interest income expense | -1.96%-22.6M | -4.12%-6.24M | -5.48%-5.53M | 0.62%-5.42M | 1.19%-5.42M | -42.85%-22.16M | -8.50%-5.99M | -3.52%-5.24M | -87.16%-5.45M | -171.30%-5.48M |
Non-operating interest income | ---- | ---- | -35.96%219K | 33.33%84K | --105K | ---- | ---- | --342K | --63K | --0 |
Non-operating interest expense | 1.96%22.6M | 4.37%5.83M | 2.94%5.75M | -0.24%5.5M | 0.73%5.52M | 42.85%22.16M | 1.16%5.58M | 10.27%5.58M | 89.32%5.51M | 171.30%5.48M |
Other net income (expense) | -86.65%2.45M | 151.55%1.46M | -71.42%369K | -97.48%389K | -78.39%228K | -72.17%18.35M | 0.34%582K | -88.94%1.29M | -60.94%15.42M | -92.57%1.06M |
Gain on sale of security | 33.44%806K | ---- | ---- | ---- | ---- | 9,966.67%604K | --0 | --604K | ---- | ---- |
Earnings from equity interest | -90.35%1.64M | 11.90%658K | -13.38%369K | -97.44%389K | -72.02%228K | -74.35%17.04M | 1.38%588K | -96.33%426K | -62.03%15.21M | -94.26%815K |
Special income (charges) | --0 | --0 | --0 | --0 | --0 | 241.72%710K | ---6K | 320.97%261K | 138.19%215K | --240K |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -241.72%-710K | --6K | -320.97%-261K | -138.19%-215K | ---240K |
Income before tax | -342.37%-9.86M | -18.22%-1.95M | -56.57%-2.48M | -121.03%-2.37M | 23.28%-3.06M | -92.01%4.07M | 61.91%-1.65M | -121.75%-1.58M | -68.96%11.29M | -134.31%-3.99M |
Income tax | -518.52%-226K | 44.90%71K | -154.10%-310K | -227.45%-65K | 2.63%78K | -93.42%54K | 131.61%49K | -168.54%-122K | -92.96%51K | 2.70%76K |
Net income | -340.00%-9.64M | -18.99%-2.02M | -48.42%-2.17M | -120.55%-2.31M | 22.80%-3.14M | -91.99%4.02M | 59.33%-1.7M | -120.58%-1.46M | -68.47%11.24M | -135.19%-4.06M |
Net income continuous Operations | -340.00%-9.64M | -18.99%-2.02M | -48.42%-2.17M | -120.55%-2.31M | 22.80%-3.14M | -91.99%4.02M | 59.33%-1.7M | -120.58%-1.46M | -68.47%11.24M | -135.19%-4.06M |
Minority interest income | 9.15%155K | 27.78%46K | 11.76%38K | 0.00%36K | -2.78%35K | -1.39%142K | -2.70%36K | -2.86%34K | 0.00%36K | 0.00%36K |
Net income attributable to the parent company | -352.80%-9.79M | -19.17%-2.07M | -47.59%-2.21M | -120.93%-2.35M | 22.62%-3.17M | -92.25%3.87M | 58.83%-1.74M | -121.16%-1.49M | -68.54%11.2M | -135.61%-4.1M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | -151.73%-493K | -113.87%-95K | -54.79%-113K | -78.61%120K | 36.54%-165K | -61.45%953K | 423.11%685K | -120.92%-73K | -68.61%561K | -260K |
Net income attributable to common stockholders | -418.42%-9.3M | 18.46%-1.98M | -47.22%-2.09M | -123.17%-2.47M | 21.68%-3.01M | -93.85%2.92M | 39.56%-2.42M | -121.18%-1.42M | -68.54%10.64M | -133.35%-3.84M |
Basic earnings per share | -425.00%-0.52 | 0.00%-0.11 | -50.00%-0.12 | -122.03%-0.13 | 19.05%-0.17 | -94.01%0.16 | 50.00%-0.11 | -121.62%-0.08 | -69.11%0.59 | -133.87%-0.21 |
Diluted earnings per share | -425.00%-0.52 | 0.00%-0.11 | -50.00%-0.12 | -122.41%-0.13 | 19.05%-0.17 | -93.98%0.16 | 50.00%-0.11 | -121.62%-0.08 | -69.63%0.58 | -133.87%-0.21 |
Dividend per share | 0.00%1 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 | 2.04%1 | 0.00%0.25 | 0.00%0.25 | 0.00%0.25 | 8.70%0.25 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |